A detailed history of Flagship Harbor Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 3,580 shares of NVS stock, worth $395,804. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,580
Previous 3,631 1.4%
Holding current value
$395,804
Previous $351,000 17.09%
% of portfolio
0.02%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$106.13 - $120.89 $5,412 - $6,165
-51 Reduced 1.4%
3,580 $411,000
Q1 2024

Apr 16, 2024

BUY
$95.27 - $108.47 $17,339 - $19,741
182 Added 5.28%
3,631 $351,000
Q4 2023

Jan 10, 2024

SELL
$92.27 - $101.54 $22,052 - $24,268
-239 Reduced 6.48%
3,449 $348,000
Q3 2023

Oct 17, 2023

SELL
$94.73 - $105.13 $17,714 - $19,659
-187 Reduced 4.83%
3,688 $375,000
Q2 2023

Jul 11, 2023

BUY
$92.52 - $104.91 $91,502 - $103,755
989 Added 34.27%
3,875 $391,000
Q1 2023

Apr 12, 2023

BUY
$80.03 - $92.81 $960 - $1,113
12 Added 0.42%
2,886 $265,000
Q4 2022

Jan 13, 2023

SELL
$75.55 - $92.52 $2,644 - $3,238
-35 Reduced 1.2%
2,874 $0
Q3 2022

Oct 13, 2022

BUY
$74.61 - $87.26 $2,611 - $3,054
35 Added 1.22%
2,909 $221,000
Q2 2022

Jul 13, 2022

SELL
$80.52 - $93.75 $1,127 - $1,312
-14 Reduced 0.48%
2,874 $243,000
Q1 2022

Apr 13, 2022

BUY
$80.11 - $90.62 $7,049 - $7,974
88 Added 3.14%
2,888 $253,000
Q4 2021

Feb 10, 2022

SELL
$79.7 - $88.13 $219,812 - $243,062
-2,758 Reduced 49.62%
2,800 $245,000
Q2 2021

Jul 26, 2021

BUY
$85.24 - $94.15 $14,405 - $15,911
169 Added 3.14%
5,558 $507,000
Q1 2021

May 03, 2021

SELL
$83.5 - $98.47 $14,111 - $16,641
-169 Reduced 3.04%
5,389 $461,000
Q4 2020

Feb 08, 2021

BUY
$78.07 - $94.43 $26,465 - $32,011
339 Added 6.5%
5,558 $525,000
Q3 2020

Oct 13, 2020

BUY
$82.14 - $91.0 $146,373 - $162,162
1,782 Added 51.85%
5,219 $453,000
Q2 2020

Jul 31, 2020

BUY
$80.93 - $91.1 $44,754 - $50,378
553 Added 19.17%
3,437 $300,000
Q1 2020

May 12, 2020

BUY
$70.67 - $99.01 $52,507 - $73,564
743 Added 34.7%
2,884 $238,000
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $17,966 - $20,313
-213 Reduced 9.05%
2,141 $203,000
Q3 2019

Oct 22, 2019

BUY
$85.54 - $94.26 $6,586 - $7,258
77 Added 3.38%
2,354 $204,000
Q2 2019

Jul 22, 2019

SELL
$75.4 - $92.8 $3,016 - $3,712
-40 Reduced 1.73%
2,277 $207,000
Q1 2019

Apr 15, 2019

BUY
$75.32 - $86.15 $5,197 - $5,944
69 Added 3.07%
2,317 $222,000
Q4 2018

Jan 28, 2019

SELL
$73.66 - $82.02 $33,220 - $36,991
-451 Reduced 16.71%
2,248 $192,000
Q3 2018

Nov 05, 2018

BUY
$66.94 - $77.43 $3,949 - $4,568
59 Added 2.23%
2,699 $233,000
Q2 2018

Aug 14, 2018

BUY
$64.91 - $73.36 $171,362 - $193,670
2,640 New
2,640 $199,000
Q4 2017

Jan 24, 2018

SELL
$72.33 - $77.64 $167,516 - $179,814
-2,316 Closed
0 $0
Q3 2017

Oct 23, 2017

BUY
$74.14 - $77.27 $171,708 - $178,957
2,316
2,316 $200,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Flagship Harbor Advisors, LLC Portfolio

Follow Flagship Harbor Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.